Staying connected to care after heart screening in Uganda
Part of Heart & circulation, Infections clinical trials.
This study tests a new way to help people who had a positive heart screening result stay in follow-up care. It aims to make sure patients and families get the care they need after screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You received a positive heart screening result in the last 24 months, or you are the parent or guardian of a child who did
- You are able to give informed consent in Acholi, Luo, or English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps deliver prevention care for rheumatic heart disease in specific districts of northern Uganda. If you live there (or provide care in the selected clinics), the program may offer extra support to help stop heart damage before it starts.
This trial uses artificial intelligence to help nurses spot early signs of rheumatic heart disease during routine screenings. It may make detection faster and more accurate.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This study looks at whether a family-based program can improve heart health for adolescents in Uganda. You and your family would work together on healthy habits over the next year.
This study tests a tool called ALRITE that helps healthcare workers decide how to care for young children with breathing problems in clinics in Uganda. The tool aims to improve decisions and outcomes for these children.
This study is testing a mobile phone program called Medly Uganda to help people living with HIV manage their health and stay connected to care. Using your phone, you may get reminders, support, and guidance to help you stay healthy.
Hear when a new Rheumatic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.